nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—Sulfathiazole—CYP19A1—polycystic ovary syndrome	0.0539	0.641	CrCbGaD
Sulfadiazine—Sulfasalazine—PPARG—polycystic ovary syndrome	0.0301	0.359	CrCbGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00395	0.00432	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00394	0.0043	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.0039	0.00426	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00383	0.00418	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00375	0.00409	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00372	0.00407	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00371	0.00405	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.0037	0.00404	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00358	0.00391	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00353	0.00386	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00347	0.00379	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00341	0.00372	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00335	0.00366	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00333	0.00363	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00332	0.00363	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00328	0.00359	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00328	0.00358	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00326	0.00356	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00324	0.00354	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00324	0.00353	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00322	0.00351	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00321	0.0035	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.0032	0.00349	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00318	0.00347	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00309	0.00338	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00309	0.00337	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00308	0.00336	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00305	0.00333	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00295	0.00322	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0029	0.00317	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00287	0.00314	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00283	0.00309	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00283	0.00309	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00277	0.00302	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.0027	0.00295	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00267	0.00292	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00267	0.00291	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00264	0.00288	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00263	0.00288	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00263	0.00287	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00263	0.00287	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00261	0.00285	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.0026	0.00284	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.0026	0.00284	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00253	0.00276	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.0025	0.00273	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00244	0.00267	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00243	0.00266	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00243	0.00266	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00241	0.00263	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.0024	0.00262	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00239	0.00261	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00234	0.00255	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00231	0.00252	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00218	0.00238	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00217	0.00237	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00214	0.00234	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00213	0.00233	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00212	0.00232	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00211	0.00231	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00209	0.00229	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00208	0.00227	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00204	0.00222	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00198	0.00216	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00198	0.00216	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00197	0.00215	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00195	0.00212	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00194	0.00212	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00193	0.00211	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00186	0.00204	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00184	0.00201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00174	0.0019	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00173	0.00189	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00172	0.00188	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00172	0.00188	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00172	0.00187	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.0017	0.00186	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0017	0.00185	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00168	0.00183	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00166	0.00181	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00159	0.00173	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.00159	0.00173	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00158	0.00173	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00157	0.00172	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00157	0.00171	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00154	0.00168	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00152	0.00166	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.0015	0.00164	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	0.0015	0.00164	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00147	0.00161	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.00147	0.0016	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00144	0.00157	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00143	0.00156	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00143	0.00156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00141	0.00154	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.0014	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00139	0.00151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	0.00137	0.0015	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	0.00137	0.0015	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00137	0.00149	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00135	0.00148	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00128	0.0014	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00128	0.00139	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	0.00127	0.00139	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	0.00127	0.00139	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00125	0.00137	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.00125	0.00137	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00124	0.00136	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.00122	0.00133	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00116	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00116	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00114	0.00124	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00113	0.00124	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00112	0.00122	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.00112	0.00122	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.00112	0.00122	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.0011	0.0012	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.0011	0.0012	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.00108	0.00118	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.00108	0.00118	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00105	0.00115	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00104	0.00114	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.00104	0.00113	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.00103	0.00113	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00103	0.00112	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00101	0.00111	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000995	0.00109	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.00095	0.00104	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000946	0.00103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000914	0.000998	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000908	0.000991	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000902	0.000984	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000897	0.00098	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000881	0.000962	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000881	0.000962	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.00086	0.000939	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000848	0.000925	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000846	0.000924	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000834	0.000911	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000821	0.000896	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000811	0.000886	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000807	0.000882	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000804	0.000878	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000739	0.000806	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000736	0.000804	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000735	0.000803	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000735	0.000803	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000732	0.000799	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00072	0.000786	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.0007	0.000765	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000698	0.000762	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000697	0.000761	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00069	0.000753	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000684	0.000746	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000682	0.000744	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000668	0.000729	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00066	0.000721	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000654	0.000714	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000641	0.0007	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000636	0.000695	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000622	0.000679	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000621	0.000678	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000602	0.000658	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000599	0.000654	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000595	0.00065	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000581	0.000635	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000581	0.000635	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000575	0.000628	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000568	0.00062	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000568	0.00062	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000561	0.000613	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000554	0.000605	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000537	0.000586	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000537	0.000586	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000532	0.000581	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000528	0.000577	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000518	0.000566	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.000518	0.000565	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000506	0.000553	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000497	0.000543	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000494	0.00054	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000491	0.000536	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.00049	0.000535	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000488	0.000532	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000487	0.000532	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000464	0.000506	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000462	0.000504	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000457	0.000499	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000457	0.000498	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000451	0.000493	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000445	0.000485	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000441	0.000481	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000437	0.000477	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000421	0.00046	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000418	0.000456	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000405	0.000442	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000402	0.000439	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.0004	0.000436	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000397	0.000433	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	0.000395	0.000431	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000393	0.000429	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	0.000384	0.00042	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000377	0.000412	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000375	0.000409	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	0.000373	0.000407	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000372	0.000406	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	0.000361	0.000394	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	0.000355	0.000388	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000342	0.000373	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000337	0.000368	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000334	0.000365	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000323	0.000353	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	0.000323	0.000352	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000322	0.000351	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	0.000314	0.000343	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000313	0.000341	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	0.000307	0.000335	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000298	0.000325	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000294	0.000321	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	0.000291	0.000318	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000288	0.000315	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000278	0.000303	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	0.000272	0.000296	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000267	0.000291	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000264	0.000288	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	0.000262	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	0.000255	0.000278	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	0.000251	0.000274	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	0.00025	0.000273	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	0.00025	0.000273	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000249	0.000272	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000245	0.000268	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000237	0.000259	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	0.000221	0.000241	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	0.00022	0.00024	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	0.000217	0.000237	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	0.000216	0.000236	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000212	0.000232	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000206	0.000225	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000194	0.000212	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	0.000179	0.000196	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	0.000177	0.000193	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	0.000176	0.000192	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	0.000173	0.000189	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000165	0.00018	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000156	0.000171	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	0.000146	0.000159	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	0.000118	0.000129	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	0.000117	0.000127	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	0.000116	0.000127	CbGpPWpGaD
